AbCellera Biologics Inc.
AbCellera Biologics Inc. (ABCL) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
abcl · stock forecast · 11 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 11 Wall Street analysts in the past 3 months
Buy
11 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$8.00
Consensus
$7.50
+39.3% upside
Low
$7.00
Median: $7.5 · Last Close: $5.38
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$7.50
39.3% upside
High Target
$8
48.6%
Low Target
$7
30.0%
Current Price
$5.38
as of today
Based on analyst price targets, the ABCL stock price prediction for the next 12 months ranges from $7 to $8. The consensus ABCL price forecast of $7.50 implies 39.3% upside from the current price of $5.38.
Short-Term Price Prediction
BullAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $5.65 | ↑ 5.00% |
1-day model range: $5.58–$5.72. Peak: $5.72 (+5.00%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $3 | -35.7% |
| 2028 | $3 | -48.3% |
| 2029 | $2 | -53.9% |
| 2030 | $2 | -56.6% |
| 2031 | — | -58.0% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ABCL · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-11-07 | Leerink Partners | Downgrade ↓ | Outperform→Market Perform |
| 2025-08-08 | Stifel | Maintains | Buy→Buy |
| 2025-07-14 | Keybanc | Maintains | Overweight→Overweight |
| 2025-05-16 | Truist Securities | Maintains | Buy→Buy |
| 2025-05-09 | Stifel | Maintains | Buy→Buy |
| 2025-04-16 | Keybanc | Maintains | Overweight→Overweight |
| 2025-03-03 | Benchmark | Maintains | Hold→Hold |
| 2025-02-28 | Stifel | Maintains | Buy→Buy |
| 2025-01-08 | Keybanc | Maintains | Overweight→Overweight |
| 2024-11-05 | Stifel | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on AbCellera Biologics Inc. (ABCL) stock. Of the recent 38 rating actions, 1 were upgrades and 2 were downgrades. 11 analysts currently cover ABCL.
Analyst Recommendation Trends
ABCL analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$32M
↓ 4.1% YoY
Revenue Next Year
$31M
↓ 3.4% YoY
EPS This Year
$-0.59
EPS Next Year
$-0.64
↑ 9.2% YoY
EPS ForecastReported vs Estimated
Analysts forecast ABCL EPS of $-0.59 for the current fiscal year, based on estimates from 5 analysts. The ABCL revenue forecast is $32M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The ABCL stock forecast is supported by two independent data sources: analyst consensus ratings from 11 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ABCL price target is $7.50 (+39.3% upside), with an analyst consensus of Buy.
The ABCL short-term stock prediction for tomorrow is $5.65 (+5.00%). The ABCL stock price prediction for 2027 estimates an average of $3. The ABCL stock prediction for 2030 projects a range of $2–$3.
AbCellera Biologics Inc. trades on NASDAQ under the ticker ABCL. The ABCL stock outlook for 2027 is broadly positive, supported by a Buy consensus among 82% of covering analysts.
Frequently asked questions
ABCL forecast · 8 questionsAccording to 11 Wall Street analysts, the average 12-month ABCL price target is $7.50, with a high forecast of $8.00 and a low of $7.00. The median price target is shown in the chart above when available. This implies +39.3% potential upside from the current price of $5.38.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.